• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死溶栓(TIMI)评分在农村医院用于不稳定型心绞痛/非ST段抬高型心肌梗死(UA/NSTEMI)的管理时是一个可靠的依据吗?

Is the thrombolysis in myocardial infarction (TIMI) score a reliable source in a rural hospital for the management of unstable angina/non-ST elevated myocardial infarctions (UA/NSTEMI)?

作者信息

Sawalha Khalid, Khan Shoaib, Suarez Edwin, Beresic Nicholas, Kamoga Gilbert-Roy

机构信息

Internal Medicine Department, White River Health System, Batesville, AR, USA.

Osteoarthritis Action Alliance, University of North Carolina, Chapel Hill, NC, USA.

出版信息

J Community Hosp Intern Med Perspect. 2021 Jun 21;11(4):446-449. doi: 10.1080/20009666.2021.1930506.

DOI:10.1080/20009666.2021.1930506
PMID:34211646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8221156/
Abstract

: The Thrombolysis in Myocardial Infarction (TIMI) score is considered a method for early risk stratification in patients with unstable angina/non-ST elevated myocardial infarctions (UA/NSTEMI). It is composed of seven factors and if present, each factor contributes a value of one point toward the TIMI risk score, making it a simple tool that does not require differential weights for each factor. A higher score implies a higher likelihood of adverse cardiac events and/or risk of mortality. A TIMI risk score ≥3 recommends early invasive management with cardiac angiography and revascularization. As per CDC study in 2014, Americans living in rural areas are more likely to die from leading causes such as cardiovascular diseases. An estimated number 25,000 deaths than their urban counterparts, which coincide with a TIMI risk score of ≥3, potentially limit the utility of the TIMI risk score in risk stratification in rural catherization laboratories. The objective of this study was to assess the reliability of TIMI score as early risk stratification in patients with unstable angina/non-ST elevated myocardial infarctions (UA/NSTEMI) in rural hospital. : A retrospective chart review study in a rural hospital was conducted for subjects that received left heart catheterizations, exercise stress tests, or chemical stress tests for a diagnosis of UA/NSTEMI. A total of 399 subjects who underwent left heart catheterization and/or stress testing were recruited for this study. A total of 153 subjects who were transferred out to a larger facility, transitioned to comfort care, refused intervention, or passed away were excluded from the study. The 246 remaining subjects were classified into two groups, those with TIMI 0-2 compared with those having TIMI ≥ 3. A null hypothesis was postulated that there was no significant difference between the two groups with regard to prevalence of either positive stress test or evidence of obstructive coronary disease following coronary angiography. T-test and Wilcoxon rank-sum analysis were performed through SPSS statistical analysis. : Formal statistical analysis using T-test as well as Wilcoxon rank-sum test comparing the two groups showed = 0.34 for T-test and = 0.60 for Wilcoxon rank-sum test. This is consistent with the postulated null hypothesis: that there is no significant difference between the two surgery groups with respect to the mean/median TIMI score. : There was no statistical difference between high and low TIMI score in the intervention of unstable angina/non-ST elevated myocardial infarctions (UA/NSTEMI) in a rural hospital.

摘要

心肌梗死溶栓(TIMI)评分被认为是不稳定型心绞痛/非ST段抬高型心肌梗死(UA/NSTEMI)患者早期风险分层的一种方法。它由七个因素组成,若存在,每个因素对TIMI风险评分贡献一分,使其成为一个简单的工具,无需对每个因素赋予不同权重。评分越高,发生不良心脏事件和/或死亡风险的可能性越高。TIMI风险评分≥3建议早期进行心脏血管造影和血运重建的侵入性治疗。根据美国疾病控制与预防中心2014年的研究,生活在农村地区的美国人死于心血管疾病等主要原因的可能性更高。估计比城市居民多25000人死亡,这与TIMI风险评分≥3相符,可能限制了TIMI风险评分在农村导管实验室风险分层中的效用。本研究的目的是评估TIMI评分作为农村医院不稳定型心绞痛/非ST段抬高型心肌梗死(UA/NSTEMI)患者早期风险分层的可靠性。

在一家农村医院进行了一项回顾性病历审查研究,对象为接受左心导管检查、运动负荷试验或化学负荷试验以诊断UA/NSTEMI的患者。本研究共招募了399名接受左心导管检查和/或负荷试验的受试者。共有153名被转至更大医疗机构、转为舒适护理、拒绝干预或去世的受试者被排除在研究之外。其余246名受试者分为两组,TIMI 0 - 2组与TIMI≥3组。提出一个零假设,即两组在负荷试验阳性率或冠状动脉造影后阻塞性冠状动脉疾病证据方面无显著差异。通过SPSS统计分析进行t检验和Wilcoxon秩和分析。

使用t检验以及Wilcoxon秩和检验对两组进行的正式统计分析显示,t检验的P值 = 0.34,Wilcoxon秩和检验的P值 = 0.60。这与假定的零假设一致:即两个手术组在平均/中位数TIMI评分方面无显著差异。

农村医院不稳定型心绞痛/非ST段抬高型心肌梗死(UA/NSTEMI)的干预中,高TIMI评分和低TIMI评分之间无统计学差异。

相似文献

1
Is the thrombolysis in myocardial infarction (TIMI) score a reliable source in a rural hospital for the management of unstable angina/non-ST elevated myocardial infarctions (UA/NSTEMI)?心肌梗死溶栓(TIMI)评分在农村医院用于不稳定型心绞痛/非ST段抬高型心肌梗死(UA/NSTEMI)的管理时是一个可靠的依据吗?
J Community Hosp Intern Med Perspect. 2021 Jun 21;11(4):446-449. doi: 10.1080/20009666.2021.1930506.
2
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.不稳定型心绞痛/非ST段抬高型心肌梗死的TIMI风险评分:一种用于预后评估和治疗决策的方法。
JAMA. 2000 Aug 16;284(7):835-42. doi: 10.1001/jama.284.7.835.
3
Data analytics approach for short- and long-term mortality prediction following acute non-ST-elevation myocardial infarction (NSTEMI) and Unstable Angina (UA) in Asians.亚洲人群急性非 ST 段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛(UA)后短期和长期死亡率的数据分析方法。
PLoS One. 2024 Feb 15;19(2):e0298036. doi: 10.1371/journal.pone.0298036. eCollection 2024.
4
Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores.ACS 风险预测中简单化是否会影响准确性?TIMI 和 GRACE 风险评分的回顾性分析。
PLoS One. 2009 Nov 23;4(11):e7947. doi: 10.1371/journal.pone.0007947.
5
Use of thrombolysis in myocardial infarction risk score to predict bleeding complications in patients with unstable angina and non-ST elevation myocardial infarction undergoing percutaneous coronary intervention.使用心肌梗死溶栓风险评分预测接受经皮冠状动脉介入治疗的不稳定型心绞痛和非ST段抬高型心肌梗死患者的出血并发症。
Cardiovasc Interv Ther. 2013 Jul;28(3):242-9. doi: 10.1007/s12928-013-0162-3. Epub 2013 Jan 30.
6
Contemporary NSTEMI management: the role of the hospitalist.当代非ST段抬高型心肌梗死的管理:住院医师的作用。
Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20.
7
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.不稳定型心绞痛/非ST段抬高型心肌梗死患者心脏生物标志物的性别差异表达:TACTICS-TIMI 18(用阿昔单抗治疗心绞痛并确定侵入性或保守策略治疗成本-心肌梗死溶栓治疗18)子研究
Circulation. 2004 Feb 10;109(5):580-6. doi: 10.1161/01.CIR.0000109491.66226.26.
8
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.上游糖蛋白IIb/IIIa抑制及冠状动脉支架置入术在不稳定型心绞痛/非ST段抬高型心肌梗死侵入性治疗中的意义:心肌梗死溶栓治疗(TIMI)IIIB试验与应用阿昔单抗治疗心绞痛并确定侵入性或保守性策略治疗费用(TACTICS)-TIMI 18试验的比较
Circulation. 2004 Feb 24;109(7):874-80. doi: 10.1161/01.CIR.0000112604.74713.35. Epub 2004 Feb 2.
9
Validity of TIMI Score for Predicting 14-Day Mortality of Non-ST Elevation Myocardial Infarction Patients.TIMI评分对预测非ST段抬高型心肌梗死患者14天死亡率的有效性。
Cureus. 2021 Jan 6;13(1):e12518. doi: 10.7759/cureus.12518.
10
Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.经过验证的风险评分可预测不稳定型心绞痛或非ST段抬高型心肌梗死后充血性心力衰竭的发生:来自OPUS-TIMI 16和TACTICS-TIMI 18的结果。
Am Heart J. 2004 Jul;148(1):173-80. doi: 10.1016/j.ahj.2003.12.018.

本文引用的文献

1
Potentially Excess Deaths from the Five Leading Causes of Death in Metropolitan and Nonmetropolitan Counties - United States, 2010-2017.大都市和县和非大都市县五个主要死因的潜在超额死亡人数-美国,2010-2017 年。
MMWR Surveill Summ. 2019 Nov 8;68(10):1-11. doi: 10.15585/mmwr.ss6810a1.
2
Widening rural-urban disparities in life expectancy, U.S., 1969-2009.预期寿命城乡差距扩大,美国,1969-2009 年。
Am J Prev Med. 2014 Feb;46(2):e19-29. doi: 10.1016/j.amepre.2013.10.017.
3
HEART score to further risk stratify patients with low TIMI scores.
HEART评分用于对TIMI评分低的患者进行进一步的风险分层。
Crit Pathw Cardiol. 2013 Mar;12(1):1-5. doi: 10.1097/HPC.0b013e31827377e1.
4
MSJAMA. Where we live: health care in rural vs urban America.《美国医学会杂志》。我们生活的地方:美国农村与城市的医疗保健
JAMA. 2002 Jan 2;287(1):108.